Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Prospective pathology-based selection criteria

From: High-dose interleukin2 – a 10-year single-site experience in the treatment of metastatic renal cell carcinoma: careful selection of patients gives an excellent outcome

Type Histological features
Favourable Less than 10 % papillary histology, and at least one favourable feature of:
• >50 % alveolar and or >50 % solid architecture
• <50 % granular cytoplasm or >50 % clear cell features
Other Histology features other than Favourable